Nav: Home

Discovery in mice could remove roadblock to more insulin production

May 20, 2019

By the time someone gets diagnosed with diabetes -- in either of its forms -- the insulin-making factory inside their body has ground to a halt, or at least a slow crawl.

And in people with obesity, insulin supply often struggles to keep up with demand -- especially if the person eats a typical Western diet.

But a new discovery made mainly in mice could provide new options for getting those factories going again. It could offer new pathways to ramping up insulin supply to get metabolism back on track in people with Type 1 and Type 2 diabetes, and obesity.

The discovery of a new way to get the mouse pancreas to make more insulin-producing beta cells, described in a new paper in Nature Immunology, was made by researchers from the University of Michigan and their colleagues. An image from the paper is featured on the journal's cover.

Boosting beta cells

Many research teams have worked to find ways to stimulating beta cell proliferation, mainly by by boosting positive cell signals. But the team behind the new paper did it in a different way, by taking away a pair of negative signals that act as a roadblock to beta cell division and growth.

The result? Beta cells divided rapidly, swelling the structures called islets inside the pancreas, and producing insulin enough to handle the high-fat diet the mice were fed. In fact, the approach only worked when the mice were getting a high-fat, Western-style diet.

The research focused on a pair of receptors called TLR2 and TLR4. Normally, they help cells throughout the body receive signals about the presence of an invader, and start ringing the alarm bells to spur the immune system to fight off infection.

But when Ling Qi, Ph.D., and his colleagues at Cornell University and the U-M Medical School studied mice that had been altered to lack both TLR2 and TLR4 in their cells, they found something surprising. When fed a high-fat diet with 60 percent of calories from fat, their pancreatic islets swelled so much they could be seen with the naked eye.

"After this initial observation, we performed additional experiments that demonstrate that these two factors work together to block beta cell proliferation," says Qi, a professor of molecular and integrative physiology and internal medicine at U-M and senior author of the new paper. "But if you take out both TRL2 and TRL4 together, those beta cells proliferate like crazy."

An unexpected turn

Qi and his colleagues originally set out to study the role of TRL2 and TRL4 in inflammation in fat tissue in animals that had developed obesity, to test ideas about the role of the immune system in this process. But when they allowed the obese mice to eat a high-fat diet, they noticed that their islets had grown very large.

This accidental discovery led them to examine what was going on - and what factors inside beta cells were affected.

They discovered that a factor that regulates the cycle of cell division and growth wasn't able to get into the nucleus of cells of mice, except when the mice lacked both TLR2 and TLR4 and received a high-fat diet.

In other words, TLR2 and TLR4 were blocking the signals needed to prompt beta cells to produce more of themselves.

The team also performed several experiments that ruled out factors circulating in the blood, or coming from other types of cells such as the liver or nerves, in prompting beta cell proliferation. The only thing remaining was the role of the pair of TLR molecules, and they both had to be absent in the islets to get beta cells to reproduce.

The mice that lacked TRL2 and TRL4 kept their new beta cells functioning, and bringing down their blood sugar even with a high-fat diet that can disrupt normal metabolism.

A new avenue to explore

The discovery of the key role of the combination of TRL2, TRL4 and diet in regulating the production of beta cells opens up new avenues for treating diabetes and obesity, says Qi. The team used human beta cells from the University of Pennsylvania to validate the finding.

But first, he notes, it will be important to understand what the role of the high-fat diet is, relative to TRL2 and TRL4. He and his colleagues are already working on that.

"Something associated with high-fat-induced obesity plays a key role in this process, but we don't yet know what," he says. He notes that in people with obesity and Type 2 diabetes, research has shown that new beta cells are made for a while, but then stop being produced.

They're also working to acquire more human beta cells and islets to study, to see if the studies in mice fully bear out in human cells.

But, Qi notes, the new discovery of the importance of "negative" factors that block beta cell proliferation means that efforts to promote beta cell growth just by amplifying "positive" factors are probably not going to work.

Making therapies based on a combination of drugs to boost positive factors and remove the negative roadblocks will probably work best, he says.

And while there are drugs that can block TLR2 and TLR4, they can't be given in a way that reaches the entire body, because they would disable the immune system. The mice in the study were living in a pathogen-free facility at U-M, so this wasn't an issue. But disabling TLR2 and TLR4 would have to be done in a islet-specific way.

The new discovery might also be useful for improving outcomes from islet transplants that are emerging as a promising experimental treatment for Type 1 diabetes. He and his team will study the effects of editing the genes of beta cells within islets before they're transplanted into mice.
The study's lead authors are U-M Physiology research investigator Yewei Ji, Ph.D., and Shengyi Sun, Ph.D., formerly of Cornell and now an Assistant Professor at Wayne State University in Detroit. Cornell University holds a patent on the discovery. Other authors are from Joslin Diabetes Center at Harvard University, the University of Virginia, Vanderbilt University, the University of Pennsylvania, and Wageningen University in the Netherlands.

The research was funded by the National Institutes of Health (DK11174, DK117639, DK089503, CA046592, DK108921, DK106304, DK091526), the Juvenile Diabetes Research Foundation (JDRF), and the Michigan Nutrition Obesity Research Center.

Reference: Nature Immunology,

Michigan Medicine - University of Michigan

Related Diabetes Articles:

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

One of the most consistent questions we get at the show is from parents who want to know which episodes are kid-friendly and which aren't. So today, we're releasing a separate feed, Radiolab for Kids. To kick it off, we're rerunning an all-time favorite episode: Space. In the 60's, space exploration was an American obsession. This hour, we chart the path from romance to increasing cynicism. We begin with Ann Druyan, widow of Carl Sagan, with a story about the Voyager expedition, true love, and a golden record that travels through space. And astrophysicist Neil de Grasse Tyson explains the Coepernican Principle, and just how insignificant we are. Support Radiolab today at